id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2015-D-3539-0030,FDA,FDA-2015-D-3539,"Interim Policy on Compounding Using Bulk Drug Substances Under Section 503B of the Federal Food, Drug, and Cosmetic Act; Guidance for Industry;
Availability",Notice,Notice of Availability,2025-01-07T05:00:00Z,2025,1,,,2025-01-07T18:39:36Z,2024-31545,0,0,09000064868a35df
FDA-2015-D-3539-0031,FDA,FDA-2015-D-3539,"Interim Policy on Compounding Using Bulk Drug Substances Under Section 503B of the Federal Food, Drug, and Cosmetic Act; Guidance for Industry",Other,Guidance,2025-01-07T05:00:00Z,2025,1,2025-01-07T05:00:00Z,,2025-10-17T09:00:21Z,,1,0,09000064868a4e3f
FDA-2015-D-3539-0019,FDA,FDA-2015-D-3539,"Interim Policy on Compounding Using Bulk Drug Substances Under Section 503B of the Federal Food, Drug, and Cosmetic Act; Draft Guidance for Industry; Availability",Notice,Notice of Availability,2023-12-07T05:00:00Z,2023,12,2023-12-07T05:00:00Z,,2023-12-07T14:46:02Z,2023-26845,0,0,090000648630b16d
FDA-2015-D-3539-0020,FDA,FDA-2015-D-3539,"Interim Policy on Compounding Using Bulk Drug Substances Under Section 503B of the Federal Food, Drug, and Cosmetic Act; Draft Guidance for Industry",Other,Guidance,2023-12-07T05:00:00Z,2023,12,2023-12-07T05:00:00Z,2024-01-09T04:59:59Z,2025-01-07T18:40:04Z,,0,0,090000648630bbba
FDA-2015-D-3539-0014,FDA,FDA-2015-D-3539,"Interim Policy on Compounding Using Bulk Drug Substances Under Section 503B of the Federal Food, Drug, and Cosmetic Act;  Guidance for Industry",Other,Guidance,2016-06-10T04:00:00Z,2016,6,2016-06-10T04:00:00Z,,2025-01-07T18:39:57Z,,0,0,090000648202e5c0
FDA-2015-D-3539-0013,FDA,FDA-2015-D-3539,"Interim Policy on Compounding Using Bulk Drug Substances Under Section 503B of the Federal Food, Drug, and Cosmetic Act; Guidance for Industry; Availability",Rule,Correction,2016-06-10T04:00:00Z,2016,6,2016-06-10T04:00:00Z,,2016-06-10T19:21:24Z,2016-13798,0,0,090000648202c009
FDA-2015-D-3539-0002,FDA,FDA-2015-D-3539,"Interim Policy on Compounding Using Bulk Drug Substances Under Section 503B of the Federal Food, Drug, and Cosmetic Act; Draft Guidance for Industry",Other,Guidance,2015-10-27T04:00:00Z,2015,10,2015-10-27T04:00:00Z,,2019-08-22T19:11:12Z,,0,0,0900006481cf1f40
FDA-2015-D-3539-0001,FDA,FDA-2015-D-3539,"Interim Policy on Compounding Using Bulk Drug Substances Under Section 503B of the Federal Food, Drug, and Cosmetic Act; Draft Guidance for Industry; Availability",Notice,Notice of Availability,2015-10-27T04:00:00Z,2015,10,2015-10-27T04:00:00Z,2015-12-29T04:59:59Z,2015-12-29T22:00:40Z,2015-27268,0,0,0900006481cf1660